Global Oral Solid Dosage Cdmo Market Size & Outlook
Global oral solid dosage cdmo market, 2021-2033 (US$M)
Related Markets
Global oral solid dosage cdmo market highlights
- The global oral solid dosage cdmo market generated a revenue of USD 43,652.4 million in 2024 and is expected to reach USD 77,056.0 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 6.6% by 2033.
- In terms of segment, tablets accounted for a revenue of USD 14,884.8 million in 2024.
- Capsules is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, Asia Pacific was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 43,652.4 million |
| Market revenue in 2033 | USD 77,056.0 million |
| Growth rate | 6.6% (CAGR from 2025 to 2033) |
| Largest segment | Tablets |
| Fastest growing segment | Capsules |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tablets, Capsules, Powders, Granules, Others Product |
Other key industry trends
- In terms of revenue, the North America accounted for 30.6% of the global oral solid dosage cdmo market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, India is the fastest growing regional market and is projected to reach USD 6,992.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oral Solid Dosage CDMO Market Scope
Oral Solid Dosage CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Rubicon Research | View profile | 251-500 | Mumbai, Maharashtra, India, Asia | http://www.rubicon.co.in/ |
| SPI Pharma | View profile | 251-500 | Wilmington, Delaware, United States, North America | http://spipharma.com |
| Aenova Group | View profile | 5001-10000 | Greensboro, North Carolina, United States, North America | http://www.aenova-group.com |
| Quotient Sciences | View profile | 251-500 | Nottingham, Nottingham, United Kingdom, Europe | https://www.quotientsciences.com/ |
| Jubilant Pharmova | View profile | 10001+ | Noida, Uttar Pradesh, India, Asia | https://www.jubilantpharmova.com |
| DPT Laboratories | View profile | 1001-5000 | San Antonio, Texas, United States, North America | https://www.dptlabs.com |
| Almac Group | View profile | 1001-5000 | Craigavon, Craigavon, United Kingdom, Europe | https://www.almacgroup.com |
| CordenPharma | View profile | 5001-10000 | Plankstadt, Baden-Wurttemberg, Germany, Europe | http://cordenpharma.com |
| Alcami | View profile | 501-1000 | Wilmington, North Carolina, United States, North America | http://www.alcaminow.com |
| Piramal Pharma Solutions | View profile | 1001-5000 | Riverview, Michigan, United States, North America | http://www.piramalpharmasolutions.com/ |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | http://www.recipharm.com |
| Chemical Works of Gedeon Richter PLC | View profile | 11901 | Gyomroi ut 19-21, Budapest, Hungary, 1103 | https://www.gedeonrichter.com/hu-hu |
| Siegfried Holding AG | View profile | 4180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | https://www.siegfried.ch |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Kuehne + Nagel International AG | View profile | 93064 | Dorfstrasse 50, P.O. Box 67, Schindellegi, Switzerland, CH-8834 | http://www.kuehne-nagel.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
Global oral solid dosage cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage cdmo market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 34.1% in 2024. Horizon Databook has segmented the Global oral solid dosage cdmo market based on tablets, capsules, powders, granules, others product covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Oral Solid Dosage CDMO Product Outlook (Revenue, USD Million, 2021-2033)
- Tablets
- Compressed Tablets
- Orally Disintegrating Tablets (ODT)
- Chewable Tablets
- Bi-layer or Tri-layer Tablets
- Sublingual or Buccal Tablets
- Others Tablets
- Capsules
- Hard Gelatin Capsules
- Soft Gelatin Capsules
- Powders
- Granules
- Others Product
- Tablets
- Global Oral Solid Dosage CDMO Mechanism Outlook (Revenue, USD Million, 2021-2033)
- Immediate Release
- Delayed Release
- Controlled Release
- Global Oral Solid Dosage CDMO Drug Potency Outlook (Revenue, USD Million, 2021-2033)
- High Potent Drugs
- Moderate Potent Drugs
- Low Potent Drugs
- Global Oral Solid Dosage CDMO End Use Outlook (Revenue, USD Million, 2021-2033)
- Large Size Companies
- Medium & Small Size Companies
- Others End Use
- Global Oral Solid Dosage CDMO Service Outlook (Revenue, USD Million, 2021-2033)
- Contract Development
- Contract Manufacturing
- Packaging and Labelling
- Regulatory Affairs
- Logistics & Storage
- Others Service
Reasons to subscribe to Global oral solid dosage cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global oral solid dosage cdmo market databook
-
Our clientele includes a mix of oral solid dosage cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global oral solid dosage cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global oral solid dosage cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global oral solid dosage cdmo market size, by regions, 2021-2033 (US$M)
Top 10 countries: Oral solid dosage cdmo market size, 2024 (US$M)
Global oral solid dosage cdmo market share, by product, 2024 & 2030 (%, US$M)
Oral solid dosage cdmo market: Opportunity assessment by country
Global oral solid dosage cdmo market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
